市場調查報告書
商品編碼
1439432
彈性體幫浦 - 全球市場考量、競爭格局、市場預測 (2030)Elastomeric Pump - Market Insights, Competitive Landscape, and Market Forecast - 2030 |
全球彈性體幫浦市場規模預計到2023年將達到5.23億美元,到2030年將達到7.65億美元,2024-2030年預測期間複合年增長率為6.54%。彈性體幫浦需求的增加主要是由於彈性體幫浦的廣泛應用、與其他類型輸液幫浦相比產品設計的簡單性以及彈性體幫浦在世界各地的可用性,這些都推動了市場的發展。預計在2024- 2030 年預測期內將加強並促進市場成長。
彈性體幫浦市場動態
由於各種原因,彈性體幫浦市場的產品需求正在成長。由於彈性體幫浦在各種應用中的使用量不斷增加,預計彈性體幫浦市場在預測期內將會增強。
彈性泵是用於注射藥物的醫療設備。根據患者所需的治療,藥物可能包括抗生素、化療藥物、5FU、細胞刺激劑、止痛劑和局部麻醉劑。
彈性幫浦是門診手術中心和家庭醫療機構中施用化療藥物的首選。此外,使用經過適當測試的彈性體幫浦可以減少化療藥物的浪費。
彈性幫浦被腫瘤學和血液學藥劑師和技術人員廣泛使用。它也廣泛受到患者的青睞,因為它可以顯著降低治療成本。
彈性泵用於各個領域,例如術前和術後疼痛管理。在術後早期,必須每天評估疼痛程度和治療併發症以調整鎮痛藥,從而增加了對可調整劑量的醫療設備的需求。
因此,彈性體泵在各個領域的使用不斷增加,將增加對彈性體泵的需求,也將促進彈性體泵市場的成長。
然而,藥物輸送準確率的問題以及未能檢測到異常藥物輸送率可能成為彈性體幫浦市場成長的一定限制因素。
持續的 COVID-19 大流行對彈性體幫浦市場產生了輕微影響,因為與冠狀病毒患者相比,癌症和其他疾病患者的住院優先順序較低。此外,在大流行期間,選擇性手術暫時停止。然而,隨著許多人接種疫苗,彈性體幫浦市場正在恢復勢頭。
彈性幫浦市場細分分析
就彈性體幫浦市場的產品類型細分而言,在預測期內(2024-2030年),連續速度彈性體輸液幫浦預計將在彈性體幫浦市場中佔據較高份額。這是由於與這些設備相關的各種好處。
預計在預測期內,對連續速度彈性輸液幫浦的需求將會增加。這是由於彈性體幫浦技術的進步。
例如,彈性體幫浦是門診抗生素治療的首選,因為它們不需要外部管道。
彈性泵還具有技術進步,可實現更長的儲存和穩定性規格,因為這些設備可以輕鬆冷藏和冷凍。
因此,連續速彈性輸液幫浦領域的技術進步將增加對連續速彈性輸液幫浦的需求,這將推動彈性幫浦市場的成長。
預計北美將主導整個彈性體幫浦市場。
在所有地區中,北美預計將在全球彈性體幫浦市場中佔據最大份額。癌症和心血管疾病等慢性病盛行率的增加將增加北美對用於向美國患者給藥的彈性泵的需求,從而導致整個彈性泵市場的成長。
本報告提供了全球彈性幫浦市場的研究和分析,包括市場規模和預測、驅動因素和挑戰以及公司和產品概況。
Elastomeric Pumps Market By Product Type (Continuous Rate Elastomeric Infusion Pumps, Variable-Rate Elastomeric Infusion Pumps, Both), By Channel Type (Single Channel, Dual Channel), By End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Others), by geography is expected to grow at a steady CAGR forecast till 2030 owing to wide application areas and affordability of elastomeric pumps
Global Elastomeric Pumps Market was valued at USD 523 Million in 2023, growing at a CAGR of 6.54% during the forecast period from 2024 to 2030 to reach USD 765 Million by 2030. The increase in demand for Elastomeric Pumps is primarily attributed to the wide application areas of elastomeric pumps, simplicity in product design compared to other types of infusion pumps, affordability of elastomeric pumps across the world are anticipated to bolster the market, thereby contributing to the growth of the Elastomeric Pumps market during the forecast period from 2024-2030.
Elastomeric Pumps Market Dynamics:
The Elastomeric Pumps market is witnessing a growth in product demand owing to various reasons. The increasing use of elastomeric pumps in various applications is anticipated to bolster the market for elastomeric pumps during the forecasted period.
An elastomeric pump is a medical device that is used for the infusion of medication. Depending on the therapy that is required by the patient, the medications comprise antibiotics, chemotherapy, 5FU, cytostatic, analgesics, and local anesthetics.
The elastomeric pumps are continuously been preferred for the administration of chemotherapeutic drugs at ambulatory surgical centers and home care settings. This also increased reduction in the wastage of chemotherapeutic drugs when being used after properly tested elastomeric pumps.
Elastomeric pumps are widely used by oncology and hematology pharmacists and technicians. The devices are also preferred by patients widely owing to a considerable reduction of their treatment costs.
Elastomeric pumps had found their use in various areas of application comprising of both pre and post-operative pain management. In the early days after post-operative surgeries, there is a daily assessment upon the aspect of pain severity and complications of treatment, in order to adjust the analgesic medications, thereby increasing the need for such medical devices that can adjust medication doses.
Thus, due to the increasing utilization of elastomeric pumps in various areas of application, there will be a rising demand for elastomeric pumps, in turn increasing the elastomeric pumps market growth.
However, problems in the accurate rate of drug delivery and failure in the detection of an abnormal rate of drug delivery may be certain limiting factors of the Elastomeric Pumps market growth.
The ongoing Coronavirus disease 2019 (COVID-19) pandemic has slightly impacted the market for elastomeric pumps as hospital admissions for patients suffering from cancers and other disorders were not a priority in comparison to the patients suffering from Coronavirus. Furthermore, elective surgeries were temporarily stopped during the pandemic. However, with masses being vaccinated, the Elastomeric Pumps market has picked momentum.
Elastomeric Pumps Market Segment Analysis:
Elastomeric Pumps Market By Product Type (Continuous Rate Elastomeric Infusion Pumps, Variable Rate Elastomeric Infusion Pumps, Both), By Channel Type (Single Channel, Dual Channel), By End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the Product Type segment of the Elastomeric Pumps market, the Continuous Rate Elastomeric Infusion Pumps are estimated to hold a higher share in the Elastomeric Pumps market during the forecast period (2024-2030). This can be ascribed to the various advantages that are associated with these devices.
The demand for continuous rate elastomeric infusion pumps is expected to increase during the forecasted period. This is owing to the rising technological advancements of elastomeric pumps.
For instance, elastomeric pumps are preferred in usage for offering outpatient antibiotic therapy, as these devices do not require any external tubing.
Elastomeric pumps also comprise technological advancements that enable longer storage and stability specifications as these devices can be readily refrigerated and frozen.
Thus, owing to the technological advancements in the area of continuous rate elastomeric infusion pumps, there will be an increase in the demand for continuous rate elastomeric infusion pumps, which in turn will drive the Elastomeric Pumps market growth.
North America is expected to dominate the overall Elastomeric Pumps Market:
Among all the regions, North America is expected to account for the largest share in the global Elastomeric Pumps market. Growing incidence of chronic diseases such as cancer, and cardiovascular diseases will increase the demand for elastomeric pumps in North America for administering drugs to patients in the United States, leading to a rise in the overall elastomeric pumps market growth.
For instance, as per the National Cancer Institute 2020, an estimated number of 1,806,590 new cases were diagnosed in the United States and about 606,520 patients will die from the disease.
Also, as per the American Cancer Society, 2020, an estimated number of 1.8 million new cancer cases were diagnosed in the United States.
Also, as per the Centers for Disease Control and Prevention, in the year 2018, 1,708,921 new cases were reported in the United States. As per the same source, for every 100,000 people, 436 new cancer cases were documented and about 149 patients were affected with cancer.
Furthermore, as per the Centers for Disease Control and Prevention, in 2022, about 659,000 people in the United States were affected with heart disorders every year.
Thus, all the above-mentioned factors are anticipated to propel the market for Elastomeric Pumps in the United States.
Elastomeric Pumps Market Key Players:
Some of the key market players operating in the Elastomeric Pumps market include B.Braun Melsungen AG, Nipro Corporation, HEKA s.r.l., Surgika, Baxter, Daiken Medical Co., Ltd, I-Flow Corp., Gamastech Innovative Infusion Systems, Samtronic Industria e Comercio LTDA, Vikymed Italia s.r.l, PAJUNK, Wolf Medical Supply, Ace Medical Co. Ltd., Leventon, S.A.U., Smiths Medical, Assut Europe, Bexen medical, MULTIMEDICAL S.r.l., Ambu Inc., Canox MD. Srl, among others.
Recent Developmental Activities in the Elastomeric Pumps Market:
In March 2022, Fresenius Kabi announced its 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for its wireless Agilia® Connect Infusion System which includes the Agilia® Volumetric Pump and the Agilia® Syringe Pump with Vigilant® Software Suite-Vigilant® Master Med technology.
Key Takeaways from the Elastomeric Pumps Market Report Study
Target Audience who can be benefited from this Elastomeric Pumps Market Report Study
Frequently Asked Questions for Elastomeric Pumps Market:
An elastomeric pump is a medical device that is used for the infusion of medication. Depending on the therapy that is required by the patient, the medications comprise antibiotics, chemotherapy, 5FU, cytostatic, analgesics, and local anesthetics.
Global Elastomeric Pumps Market was valued at USD 523 Million in 2023, growing at a CAGR of 6.54% during the forecast period from 2024 to 2030 to reach USD 765 Million by 2030.
The Elastomeric Pumps market is witnessing a positive market growth owing to the wide application areas of elastomeric pumps, simplicity in product design compared to other types of infusion pumps, affordability of elastomeric pumps across the world are anticipated to bolster the market.
Some of the key market players operating in the Elastomeric Pumps market include B.Braun Melsungen AG, Nipro Corporation, HEKA s.r.l., Surgika, Baxter, Daiken Medical Co., Ltd, I-Flow Corp., Gamastech Innovative Infusion Systems, Samtronic Industria e Comercio LTDA, Vikymed Italia s.r.l, PAJUNK, Wolf Medical Supply, Ace Medical Co. Ltd., Leventon, S.A.U., Smiths Medical, Assut Europe, Bexen medical, MULTIMEDICAL S.r.l., Ambu Inc., Canox MD. Srl and others.
North America is expected to hold the highest share in the revenue in the Elastomeric Pumps market during the forecast period. Growing incidence of chronic diseases such as cancer, and cardiovascular diseases will increase the demand for elastomeric pumps in North America for administering drugs to patients in the United States, leading to a rise in the overall elastomeric pumps market growth in this region.